The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Major Depressive Disorder
MEDIMIND
1 other identifier
interventional
64
1 country
1
Brief Summary
The present study investigates the effect of Mediterranean Diet and Mindful Eating on depression severity in people with obesity and major depressive disorder. The factorial design allows to investigate potential synergistic effects of the interventions. Participants will be randomized to one of the four intervention groups (mediterranean diet, mindful eating, their combination and a befriending control group). The intervention consists of a 12-week period, followed by a 12-week follow up. The primary outcome is depression severity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2024
CompletedFirst Posted
Study publicly available on registry
October 1, 2024
CompletedStudy Start
First participant enrolled
November 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedApril 8, 2025
November 1, 2024
4 months
September 23, 2024
April 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depression severity
Beck Depression Inventory - II (BDI-II) scores range from 0 to 63 with higher scores indicating higher depression severity
12 weeks
Secondary Outcomes (16)
Depression severity, self assessment
24 weeks
Depression Remission Rates
12 weeks, 24 weeks
Quality of Life
12 weeks, 24 weeks
Self-efficacy
12 weeks, 24 weeks
Health status
12 weeks,
- +11 more secondary outcomes
Study Arms (4)
Mediterranean Diet
EXPERIMENTALMindful Eating
EXPERIMENTALMediterranean Diet and Mindful Eating
EXPERIMENTALBefriending
SHAM COMPARATORInterventions
nutritional intervention to mediterranean diet
intervention regarding mindful eating, e.g. attention while eating, apprechiation of food
Befreinding Control Group: Provision of same amout of time and attention, without having an intervention, e.g. talking about hobbies and interests, playing card games
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Presence of clinically diagnosed major depression
- At least moderate depression severity: BDI-II ≥ 20
- obesity: BMI ≥ 30 kg/m2
- Stable co-intervention: no change in the type, dosage or frequency of antidepressant medication and/or psychotherapy four weeks before and during the study
- Low adherence to the mediterranean diet: MEDAS \< 10
- Low adherence to mindful eating: MEI \< 5.13
You may not qualify if:
- Diseases of the gastrointestinal tract that do not allow adequate implementation of the intervention (e.g. irritable bowel syndrome, post-bariatric surgery, colorectal carcinoma)
- Metabolic diseases with strong impact on intervention (e.g. type 1 diabetes mellitus, chronic kidney disease)
- Severe food allergies and intolerances, that do not allow adequate implementation of the intervention
- Diagnosed, current psychological comorbidities (bipolar disorder, eating disorder, personality disorder, psychosis)
- intake of antibiotics in the last three months current substance abuse
- Pregnancy and breatfeeding
- Suicidal ideation
- unable to participate or complete questionnaires
- Healthy Volunteers:
- samples of 32 healthy volunteers are included for microbiome analysis only (
- age ≥ 18 years
- BMI 20 - 30 kg/m\^2
- depression or other psychological comorbidities (bipolar disorder, eating disorder, personality disorder, psychosis)
- high adhernece to mediterranean diet: MEDAS ≥ 10
- high adherence to mindful eating: MEI ≥ 5.13
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- Robert Bosch Center for Integrative Medicine and Healthcollaborator
- Department of Psychosomatic Medicine, Robert Bosch Hospital Stuttgartcollaborator
- Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingencollaborator
Study Sites (1)
Robert Bosch Center for Integrative Medicine and Health
Stuttgart, 70376, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- data analysis will be conducted blinded
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2024
First Posted
October 1, 2024
Study Start
November 5, 2024
Primary Completion
March 1, 2025
Study Completion
September 1, 2025
Last Updated
April 8, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share